{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:45:51Z","timestamp":1790221551014,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS36157"],"award-info":[{"award-number":["NS36157"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.expneurol.2006.09.004","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T16:02:11Z","timestamp":1161187331000},"page":"512-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease"],"prefix":"10.1016","volume":"203","author":[{"given":"G.D.","family":"Zeevalk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Manzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Sonsalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2006.09.004_bib1","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","article-title":"A generalized increase in protein carbonyls in the brain in Parkinson's disease but not incidental Lewy body disease","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.09.004_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2007-1007174","article-title":"Glutathione therapy: from prodrugs to genes","volume":"18","author":"Anderson","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.expneurol.2006.09.004_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0003-9861(85)90723-4","article-title":"Glutathione monoethyl ester: preparation, uptake by tissues and conversion to glutathione","volume":"239","author":"Anderson","year":"1985","journal-title":"Arch. Biochem. Biophsy."},{"key":"10.1016\/j.expneurol.2006.09.004_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jnr.20394","article-title":"Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against AB(1\u201342)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"79","author":"Boyd-Kimball","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2006.09.004_bib5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1210\/endo-103-4-1297","article-title":"Blood\u2013brain barrier restriction of peptides and the low uptake of enkephalins","volume":"103","author":"Cornford","year":"1978","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2006.09.004_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.870090115","article-title":"Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study","volume":"9","author":"Dexter","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2006.09.004_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410350107","article-title":"Indexes of oxidative stress and mitochondrial-function in individuals with incidental Lewy body disease","volume":"35","author":"Dexter","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib8","series-title":"Glutathione: Chemical, Biochemical and Medical Aspects","first-page":"22","author":"Dolphin","year":"1989"},{"key":"10.1016\/j.expneurol.2006.09.004_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/35046114","article-title":"Coenzyme Q is an obligatory cofactor for uncoupling protein function","volume":"408","author":"Echtay","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2006.09.004_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/415096a","article-title":"Superoxide activates mitochondrial uncoupling proteins","volume":"415","author":"Echtay","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2006.09.004_bib11","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/ana.410320722","article-title":"A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease","volume":"32","author":"Fahn","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib12","first-page":"71","article-title":"Glutathione status, glutathione monoisopropyl ester, and cadmium metabolism in mice","volume":"70","author":"Gale","year":"1990","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0954-6111(97)90052-4","article-title":"Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro","volume":"91","author":"Gillissen","year":"2006","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.expneurol.2006.09.004_bib14","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","article-title":"Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease","volume":"32","author":"Jenner","year":"1992","journal-title":"Ann.Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib15","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI114666","article-title":"Evidence for carrier-mediated transport of glutathione across the blood brain barrier in the rat","volume":"85","author":"Kannan","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2006.09.004_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-4159.1983.tb08109.x","article-title":"Amino acids in the substantia nigra of rats with striatal lesions produced by kainic acid","volume":"40","author":"Korf","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.09.004_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/106002809502901213","article-title":"Glutathione in health and disease: pharmacotherapeutic issues","volume":"29","author":"Lomaestro","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.expneurol.2006.09.004_bib18","first-page":"287","article-title":"Human plasma glutathione oxidation in normal and pathological conditions","volume":"2","author":"Magnani","year":"1984","journal-title":"Clin. Physiol. Biochem."},{"key":"10.1016\/j.expneurol.2006.09.004_bib19","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/carcin\/16.9.2099","article-title":"Uptake and distribution of N-acetylcysteine in mice: tissue specific effects on glutathione concentrations","volume":"16","author":"McLellan","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.expneurol.2006.09.004_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(91)90076-X","article-title":"Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy","volume":"51","author":"Meister","year":"1991","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2006.09.004_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/jnr.20107","article-title":"Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration","volume":"76","author":"Munoz","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2006.09.004_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1046\/j.1471-4159.1995.64031088.x","article-title":"A possible role of glutathione as an endogenous agonist at the N-methyl-d-aspartate recognition domain in rat brain","volume":"64","author":"Ogita","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.09.004_bib23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.2185543","article-title":"l-cysteine, a bicarbonate-sensitive endogenous excitotoxin","volume":"248","author":"Olney","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2006.09.004_bib24","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1074\/jbc.M302297200","article-title":"Coenzyme Q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property","volume":"278","author":"Papucci","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2006.09.004_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2004.03.072","article-title":"Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease","volume":"3633","author":"Park","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2006.09.004_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib27","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.expneurol.2006.09.004_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","article-title":"Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients","volume":"67","author":"Perry","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2006.09.004_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(95)01139-0","article-title":"Neurotoxicity of cysteine: interaction with glutamate","volume":"705","author":"Puka-Sundvall","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.09.004_bib30","first-page":"197","article-title":"A marker of oxyradical-mediated DNA damage (8-hydroxy-2\u2032-deoxyguanosine) is increased in nigrostriatum of Parkinson's disease brain","volume":"3","author":"Sanchez-Ramos","year":"1994","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.expneurol.2006.09.004_bib31","first-page":"F911","article-title":"Effect of an altered glutathione content on renal ischemic injury","volume":"255","author":"Scaduto","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib32","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"3","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.09.004_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0278-5846(96)00103-0","article-title":"Reduced intravenous glutathione in the treatment of early Parkinson's disease","volume":"20","author":"Sechi","year":"1996","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2006.09.004_bib34","first-page":"S160","article-title":"DATATOP: a decade of neuroprotective inquiry. Parkinson study group. Deprenyl and tocopherol antioxidative therapy of Parkinsonism","volume":"44","author":"Shoulson","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib35","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson's disease","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1152\/jappl.1989.66.3.1029","article-title":"Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester","volume":"66","author":"Tsan","year":"1989","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1471-4159.1982.tb12548.x","article-title":"Cysteine and cystine transport at the blood\u2013brain barrier","volume":"37","author":"Wade","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.09.004_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0031-6997(24)01370-X","article-title":"Endogenous glutathione conjugates: occurrence and biological functions","volume":"50","author":"Wang","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.expneurol.2006.09.004_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2006.02.002","article-title":"Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)","volume":"200","author":"Yazdani","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.09.004_bib41","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2006.09.004_bib42","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/ars.2005.7.662","article-title":"Energy status, oxidative stress and ubiquitin proteasomal function during chronic and acute complex I inhibition with rotenone in mesencephalic cultures","volume":"7","author":"Zeevalk","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2006.09.004_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-4522(99)00567-9","article-title":"Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity","volume":"96","author":"Zeevalk","year":"2000","journal-title":"Neuroscience"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606005401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606005401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:33:17Z","timestamp":1758000797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488606005401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0014488606005401"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.09.004","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}